Obesity Drugs and Therapies: Technologies and Global Markets

  • ID: 3743718
  • Report
  • Region: Global
  • BCC Research
15 % OFF
until Dec 31st 2018
1 of 5
Obesity Epidemic Sends Market for FDA-Approved Drugs Soaring

FEATURED COMPANIES

  • A.M.I. Gmbh Austria
  • BFKW
  • Endosphere Inc.
  • Mannkind Corp.
  • ONO Pharmaceuticals
  • Saniona
  • MORE
The global market for obesity treatments should reach over $7.8 billion by 2021 from over $4.3 billion in 2016 at a compound annual growth rate (CAGR) of 12.7% from 2016 to 2021.

This report provides:

- An overview of the global markets for obesity drugs, therapies, and related technologies.
- Analyses of global market trends, with data from 2014, 2015, estimates of 2016, and projects CAGRs through 2021.
- Focus on therapies for obesity that are U.S. FDA approved or allowed through doctors’ permission in the U.S., namely liposuction and bariatric surgery as well as FDA approved medications.
- Bariatric surgery, broken down into four procedures: Gastric Bypass, Sleeve Gastrectomy, Adjustable Gastric Band, and Biliopancreatic Diversion with Duodenal Switch (BPD/DS).
- Information covering obesity pharmaceuticals and surgeries, outlines of various drug and surgery types, a history of the market, and challenges and obstacles as well as those hurdles that have been overcome.
- Evaluation of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
- A look at the industry's structure, and the landscape of the market.
- Profiles of major players in the field.

Scope of the report:

The scope of this study encompasses companies that are involved in obesity treatment and prevention of relapse into weight gain. The report analyzes each technology or therapy type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • A.M.I. Gmbh Austria
  • BFKW
  • Endosphere Inc.
  • Mannkind Corp.
  • ONO Pharmaceuticals
  • Saniona
  • MORE
Chapter 1: Introduction
- Study Goal And Objectives
- Scope Of Report
- Intended Audience
- Methodology
- Information Sources
- Analyst's Credentials

Chapter 2: Executive Summary

- Where Progress Was
- Key Drivers
- Key Challenges
- Key Trends

Chapter 3: Obesity Overview And Background

- Obesity Explained
- Table 1 : BMI Categories

Chapter 4: Market Overview And Forecast

- Overall Pharma Market
- Diabetes As Sales Territory
- Biologics And GLP-1 Receptor Agonist Production
- Biologic Landscape
- Obesity Treatments Within The Pharma Landscape
- Market Landscape
- Deals In The Obesity Market
- Brief History Of Obesity Drugs
- Recent Trends And Obesity Therapy Approvals

Chapter 5: Development Pipeline Detailed

- Device Approval Process
- Benefit/Risk Model For Fda Clinical Trials
- Moving Obesity Drugs Through The Fda
- Patents
- Development Pipeline

Chapter 6: Company Profiles

- Allurion Technologies
- A.M.I. Gmbh Austria
- Amunix
- Apollo Endosurgery Inc.
- Arena Pharmaceuticals Inc.
- Arisaph
- Aspire Bariatrics Inc.
- Astrazeneca
- Athersys Inc.
- Baronova Inc.
- Becton, Dickinson And Co.
- BFKW
- Boehringer Ingelheim Gmbh
- Bristol-Myers Squibb
- Circuit Therapeutics Inc.
- Conjuchem
- C.R. Bard Inc.
- Dong-A Socio Holdings
- Eisai
- Eli Lilly And Co.
- Emisphere Technologies Inc.
- Endobetix
- Endosphere Inc.
- Enteromedics Inc.
- Ethicon Endo-Surgery Llc
- Gelesis Inc.
- GI Dynamics Inc.
- Glaxosmithkline Plc
- Hanmi Pharmaceutical Co. Ltd.
- Helioscopie
- Intarcia Therapeutics Inc.
- Intrapace Inc.
- Intrexon Corp.
- Johnson & Johnson
- Ligand Pharmaceuticals Inc.
- Lightlake Therapeutics Inc.
- Mannkind Corp.
- Medtronic
- Merck
- Merrion Pharmaceuticals Ltd.
- Metacure Germany Gmbh
- Mid-Medical Innovation Development
- Mitsubishi Tanabe Pharma Corp.
- Neothetics Inc.
- Ngm Biopharmaceuticals Inc.
- Norgine B.V.
- Novartis International Ag
- Novo Nordisk A/S
- Obalon Therapeutics
- Onciomed
- ONO Pharmaceuticals
- OPKO Biologics
- Oramed Pharmaceuticals
- Orexigen
- Palatin Technologies Inc.
- Pfizer
- Phasebio Pharmaceuticals Inc.
- Plensat Inc.
- Reshape Medical Inc.
- Rhythm
- Roche
- Saniona
- Sanofi
- Satrx LLC
- Scientific Intake
- Shire Pharmaceuticals Inc.
- Spatz Fgia
- Symmetry Therapeutics Inc.
- Takeda Pharmaceutical Co. Ltd.
- Transition Therapeutics Inc.
- Tulip Medical
- Valentx
- Vivus Inc.
- VTV Therapeutics Inc.
- W.L. Gore And Associates
- Zafgen
- Zealand Pharma A/S
- Zosano Pharma Corp.

List Of Tables

Summary Table : Global Market For Obesity Treatments By Type, Through 2021
Table 1 : Bmi Categories
Table 2 : Key Adipocytokines And Main Effects
Table 3 : Medications In Development For Binge Eating
Table 4 : Commercialized Incretin Therapy
Table 5 : Advantages To Adding Incretin Therapy
Table 6 : Glp-1 Receptor Agonists In Late-Stage Development
Table 7 : Glp-1 Receptor Agonists In Early-Stage Development
Table 8 : Revenue Of Top Pharma Companies, 2014
Table 9 : Biologics In Development In The U.S. By Therapeutic Category, 2013
Table 10 : Key Agreements Around Obesity Treatments
Table 11 : Timeline Of Obesity Medication Approvals
Table 12 : Fda-Approved Longer-Term Anti-Obesity Medications' Mechanism Of Action And Weight-Loss Statistics In Clinical Trials
Table 13 : Pros And Cons Of Bariatric Surgery
Table 14 : Differences Between The Obesity Surgeries
Table 15 : Timeline Of Obesity Device Approvals
Table 16 : Bariatric Surgery Spending In Europe, 2012
Table 17 : Fda Benefit-Risk Assessment For Obesity Device Clinical Trials
Table 18 : Target Effectiveness Levels For Total Body Weight Lost (Tbl)
Table 19 : Obesity Drugs In Development
Table 20 : Obesity Drug And Device Development Resources

List Of Figures

Summary Figure : Global Market For Obesity Treatments By Type, 2014-2021
Figure 1 : Main Signaling Areas Targeted For Obesity Intervention
Figure 2 : Ada's Standard Of Medical Care In Diabetes, 2014
Figure 3 : Percentage Of Dispensed Prescriptions For Glp-1 Receptor Agonists, 2012
Figure 4 : Global Market Share Of Pharmaceutical Drugs By Region, 2014 And 2019
Figure 5 : Number Of Commercialized Obesity Drugs And Device Therapeutics, 2016 And 2021
Figure 6 : Number Of Commercialized Bariatric Surgeries Minus Bands And Balloons, 2016 And 2021
Figure 7 : Number Of Commercialized Obesity Therapies By Mechanism Of Action, 2016 And 2021
Figure 8 : Global Market For Commercialized Obesity Therapies By Mechanism Of Action, 2016 And 2021
Figure 9 : Number Of Commercialized Obesity Treatments By Dosing Type, 2016 And 2021
Figure 10 : Global Market Of Commercialized Obesity Treatments By Dosing Type, 2016 And 2021
Figure 11 : Four Most Common U.S. Bariatric Procedures
Figure 12 : Case Mix Of Bariatric Surgeries In The U.S., 2014
Figure 13 : Maestro Rechargeable System
Figure 14 : Number Of Commercialized Obesity Devices*, 2016 And 2021
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Allurion Technologies
- A.M.I. Gmbh Austria
- Amunix
- Apollo Endosurgery Inc.
- Arena Pharmaceuticals Inc.
- Arisaph
- Aspire Bariatrics Inc.
- Astrazeneca
- Athersys Inc.
- Baronova Inc.
- Becton, Dickinson And Co.
- BFKW
- Boehringer Ingelheim Gmbh
- Bristol-Myers Squibb
- Circuit Therapeutics Inc.
- Conjuchem
- C.R. Bard Inc.
- Dong-A Socio Holdings
- Eisai
- Eli Lilly And Co.
- Emisphere Technologies Inc.
- Endobetix
- Endosphere Inc.
- Enteromedics Inc.
- Ethicon Endo-Surgery Llc
- Gelesis Inc.
- GI Dynamics Inc.
- Glaxosmithkline Plc
- Hanmi Pharmaceutical Co. Ltd.
- Helioscopie
- Intarcia Therapeutics Inc.
- Intrapace Inc.
- Intrexon Corp.
- Johnson & Johnson
- Ligand Pharmaceuticals Inc.
- Lightlake Therapeutics Inc.
- Mannkind Corp.
- Medtronic
- Merck
- Merrion Pharmaceuticals Ltd.
- Metacure Germany Gmbh
- Mid-Medical Innovation Development
- Mitsubishi Tanabe Pharma Corp.
- Neothetics Inc.
- Ngm Biopharmaceuticals Inc.
- Norgine B.V.
- Novartis International Ag
- Novo Nordisk A/S
- Obalon Therapeutics
- Onciomed
- ONO Pharmaceuticals
- OPKO Biologics
- Oramed Pharmaceuticals
- Orexigen
- Palatin Technologies Inc.
- Pfizer
- Phasebio Pharmaceuticals Inc.
- Plensat Inc.
- Reshape Medical Inc.
- Rhythm
- Roche
- Saniona
- Sanofi
- Satrx LLC
- Scientific Intake
- Shire Pharmaceuticals Inc.
- Spatz Fgia
- Symmetry Therapeutics Inc.
- Takeda Pharmaceutical Co. Ltd.
- Transition Therapeutics Inc.
- Tulip Medical
- Valentx
- Vivus Inc.
- VTV Therapeutics Inc.
- W.L. Gore And Associates
- Zafgen
- Zealand Pharma A/S
- Zosano Pharma Corp.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll